The controversial role of phosphodiesterase type 5 inhibitors in the treatment of premature ejaculation

Journal of Sexual Medicine

Volumn 8, Issue 8, 2011, Pages 2135-2143

  Jannini, Emmanuele A ^a   Mcmahon, Chris ^b   Chen, Juza ^c   Aversa, Antonio ^d   Perelman, Michael ^e  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b Australian Centre for Sexual Health   (Australia)

^c TEL AVIV UNIVERSITY   (Israel)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

Ejaculation; PDE5 Inhibitor; Premature Ejaculation; Sildenafil; SSRI; Tadalafil; Vardenfil

Indexed keywords

FLUOXETINE; NITRIC OXIDE; PAROXETINE; PHOSPHODIESTERASE V INHIBITOR; PLACEBO; SILDENAFIL; TADALAFIL; VARDENAFIL;

ARTICLE; DRUG DOSE INCREASE; DRUG MECHANISM; HUMAN; NONHUMAN; OUTCOME ASSESSMENT; PREMATURE EJACULATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 79960802998     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2011.02401.x     Document Type: Article

References (58)

1. McMahon CG, Althof SE, Waldinger MD, Porst H, Dean J, Sharlip ID, Adaikan PG, Becher E, Broderick GA, Buvat J, Dabees K, Giraldi A, Giuliano F, Hellstrom WJ, Incrocci L, Laan E, Meuleman E, Perelman MA, Rosen RC, Rowland DL, Segraves R. An evidence-based definition of lifelong premature ejaculation: Report of the International Society for Sexual Medicine (ISSM) ad hoc committee for the definition of premature ejaculation. J Sex Med 2008;5:1590-606.
2. Althof SE, Abdo CHN, Dean J, Hackett G, McCabe M, McMahon CG, Rosen RC, Sadovsky R, Waldinger M, Becher E, Broderick GA, Buvat J, Goldstein I, El-Meliegy AI, Giuliano F, Hellstrom WJG, Incrocci L, Jannini EA, Park K, Parish S, Porst H, Rowland D, Segraves R, Sharlip I, Simonelli C, Meng Tan H. International Society for Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculation. J Sex Med 2010;7:2947-69.
3. Rowland D, McMahon CG, Abdo C, Chen J, Jannini E, Waldinger MD, Ahn TY. Disorders of orgasm and ejaculation in men. J Sex Med 2010;7:1668-86.
4. Jannini EA, Maggi M, Lenzi A. Evaluation of premature ejaculation. J Sex Med 2011 May 6 [Epub ahead of print] doi: 10.1111/j.1743-6109.2011.02289.x.
5. McMahon C, Kim SW, Park NC, Chang CP, Rivas D, Tesfaye F, Rothman M, Aquilina J. Treatment of premature ejaculation in the Asia-Pacific region: Results from a phase III double-blind, parallel-group study of dapoxetine. J Sex Med 2010;7:256-68.
6. Jannini EA, Lenzi A. Ejaculatory disorders: Epidemiology and current approaches to definition, classification and subtyping. World J Urol 2005;23:68-75.
7. Abdel-Hamid IA, Jannini EA, Andersson KE. Premature ejaculation: Focus on therapeutic targets. Expert Opin Ther Targets 2009;13:175-93.
8. Mancina R, Filippi S, Marini M, Morelli A, Vignozzi L, Salonia A, Montorsi F, Mondaini N, Vannelli GB, Donati S, Lotti F, Forti G, Maggi M. Expression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferens. Mol Hum Reprod 2005;11:107-15.
9. Uckert S, Oelke M, Stief CG, Andersson KE, Jonas U, Hedlund P. Immunohistochemical distribution of cAMP- and cGMP-phosphodiesterase (PDE) isoenzymes in the human prostate. Eur Urol 2006;49:740-5.
10. Medina P, Segarra G, Torondel B, Chuan P, Domenech C, Vila JM, Lluch S. Inhibition of neuroeffector transmission in human vas deferens by sildenafil. Br J Pharmacol 2000;131:871-4.
11. Uckert S, Bazrafshan S, Scheller F, Mayer ME, Jonas U, Stief CG. Functional responses of isolated human seminal vesicle tissue to selective phosphodiesterase inhibitors. Urology 2007;70:185-9.
12. Kriegsfeld LJ, Demas GE, Huang PL, Burnett AL, Nelson RJ. Ejaculatory abnormalities in mice lacking the gene for endothelial nitric oxide synthase (eNOS-/-). Physiol Behav 1999;67:561-6.
13. Hull EM, Lumley LA, Matuszewich L, Dominguez J, Moses J, Lorrain DS. The roles of nitric oxide in sexual function of male rats. Neuropharmacology 1994;33:1499-504.
14. McMahon CG, McMahon CN, Leow LJ, Winestock CG. Efficacy of type-5 phosphodiesterase inhibitors in the drug treatment of premature ejaculation: A systematic review. BJU Int 2006;98:259-72.
15. McMahon CG, Stuckey BG, Andersen M, Purvis K, Koppiker N, Haughie S, Boolell M. Efficacy of sildenafil citrate (Viagra) in men with premature ejaculation. J Sex Med 2005;2:368-75.
16. Fein RL. Intracavernous medication for treatment of premature ejaculation. Urology 1990;35:301-3.
17. Abdel-Hamid IA, El Naggar EA, El Gilany AH. Assessment of as needed use of pharmacotherapy and the pause-squeeze technique in premature ejaculation. Int J Impot Res 2001;13:41-5.
18. Salonia A, Maga T, Colombo R, Scattoni V, Briganti A, Cestari A, Guazzoni G, Rigatti P, Montorsi F. A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation. J Urol 2002;168:2486-9.
19. Chen J, Mabjeesh NJ, Matzkin H, Greenstein A. Efficacy of sildenafil as adjuvant therapy to selective serotonin reuptake inhibitor in alleviating premature ejaculation. Urology 2003;61:197-200.
20. Jannini EA, Lombardo F, Lenzi A. Correlation between ejaculatory and erectile dysfunction. Int J Androl 2005;28(2 suppl):40-5.
21. Montague DK, Jarow J, Broderick GA, Dmochowski RR, Heaton JP, Lue TF, Nehra A, Sharlip ID. AUA guideline on the pharmacologic management of premature ejaculation. J Urol 2004;172:290-4.
22. Jannini EA, Lenzi A, Isidori A, Fabbri A. Subclinical erectile dysfunction: Proposal for a novel taxonomic category in sexual medicine. J Sex Med 2006;3:787-93.
23. Cappelleri JC, Rosen RC. The Sexual Health Inventory for Men (SHIM): A 5-year review of research and clinical experience. Int J Impot Res 2005;17:307-19.
24. McMahon CG. Screening for erectile dysfunction in men with lifelong premature ejaculation-Is the Sexual Health Inventory for Men (SHIM) reliable? J Sex Med 2009;6:567-73.
25. Abdel-Hamid IA. Phosphodiesterase 5 inhibitors in rapid ejaculation: Potential use and possible mechanisms of action. Drugs 2004;64:13-26.
26. Morelli A, Filippi S, Mancina R, Luconi M, Vignozzi L, Marini M, Orlando C, Vannelli GB, Aversa A, Natali A, Forti G, Giorgi M, Jannini EA, Ledda F, Maggi M. Androgens regulate phosphodiesterase type 5 expression and functional activity in corpora cavernosa. Endocrinology 2004;145:2253-63.
27. McMahon CG, Althof SE, Kaufman JM, Buvat J, Levine SB, Aquilina JW, Tesfaye F, Rothman M, Rivas DA, Porst H. Efficacy and safety of dapoxetine for the treatment of premature ejaculation: Integrated analysis of results from five phase 3 trials. J Sex Med 2011;8:524-39.
28. Waldinger MD, Hengeveld MW, Zwinderman AH, Olivier B. Effect of SSRI antidepressants on ejaculation: A double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline. J Clin Psychopharmacol 1998;18:274-81.
29. Mamas MA, Reynard JM, Brading AF. Nitric oxide and the lower urinary tract: Current concepts, future prospects. Urology 2003;61:1079-85.
30. McMahon CG. Clinical trial methodology in premature ejaculation observational, interventional, and treatment preference studies-Part I-Defining and selecting the study population. J Sex Med 2008;5:1805-16.
31. McMahon CG. Clinical trial methodology in premature ejaculation observational, interventional, and treatment preference studies-Part II-Study design, outcome measures, data analysis, and reporting. J Sex Med 2008;5:1817-33.
32. Aversa A, Pili M, Francomano D, Bruzziches R, Spera E, La Pera G, Spera G. Effects of vardenafil administration on intravaginal ejaculatory latency time in men with lifelong premature ejaculation. Int J Impot Res 2009;21:221-7.
33. Corona G, Petrone L, Mannucci E, Jannini EA, Mansani R, Magini A, Giommi R, Forti G, Maggi M. Psycho-biological correlates of rapid ejaculation in patients attending an andrologic unit for sexual dysfunctions. Eur Urol 2004;46:615-22.
34. Laumann EO, Nicolosi A, Glasser DB, Paik A, Gingell C, Moreira E, Wang T. Sexual problems among women and men aged 40-80y: Prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impot Res 2005;17:39-57.
35. Chia S. Management of premature ejaculation-A comparison of treatment outcome in patients with and without erectile dysfunction. Int J Androl 2002;25:301-5.
36. Mathers MJ, Klotz T, Roth S, Lummen G, Sommer F. Safety and efficacy of vardenafil versus sertraline in the treatment of premature ejaculation: A randomised, prospective and crossover study. Andrologia 2009;41:169-75.
37. Sato Y, Christ GJ, Horita H, Adachi H, Suzuki N, Tsukamoto T. The effects of alterations in nitric oxide levels in the paraventricular nucleus on copulatory behavior and reflexive erections in male rats. J Urol 1999;162:2182-5.
38. Sato Y, Zhao W, Christ GJ. Central modulation of the NO/cGMP pathway affects the MPOA-induced intracavernous pressure response. Am J Physiol Regul Integr Comp Physiol 2001;281:R269-78.
39. Jen PY, Dixon JS, Gosling JA. Co-localization of nitric oxide synthase, neuropeptides and tyrosine hydroxylase in nerves supplying the human post-natal vas deferens and seminal vesicle. Br J Urol 1997;80:291-9.
40. Jain NK, Patil CS, Singh A, Kulkarni SK. Sildenafil-induced peripheral analgesia and activation of the nitric oxide-cyclic GMP pathway. Brain Res 2001;909:170-8.
41. Atan A, Basar MM, Tuncel A, Ferhat M, Agras K, Tekdogan U. Comparison of efficacy of sildenafil-only, sildenafil plus topical EMLA cream, and topical EMLA-cream-only in treatment of premature ejaculation. Urology 2006;67:388-91.
42. Wang WF, Wang Y, Minhas S, Ralph DJ. Can sildenafil treat primary premature ejaculation? A prospective clinical study. Int J Urol 2007;14:331-5.
43. Jannini EA, Lenzi A. Epidemiology of premature ejaculation. Curr Opin Urol 2005;15:399-403.
44. Porst H, Montorsi F, Rosen RC, Gaynor L, Grupe S, Alexander J. The Premature Ejaculation Prevalence and Attitudes (PEPA) survey: Prevalence, comorbidities, and professional help-seeking. Eur Urol 2007;51:816-23; discussion 824.
45. Loughney K, Hill TR, Florio VA, Uher L, Rosman GJ, Wolda SL, Jones BA, Howard ML, McAllister-Lucas LM, Sonnenburg WK, Francis SH, Corbin JD, Beavo JA, Ferguson K. Isolation and characterization of cDNAs encoding PDE5A, a human cGMP-binding, cGMP-specific 3', 5'-cyclic nucleotide phosphodiesterase. Gene 1998;216:139-47.
46. Bultmann R, Klebroff W, Starke K. Nucleotide-evoked relaxation of rat vas deferens: Possible mechanisms. Eur J Pharmacol 2002;436:135-43.
47. Uckert S, Bazrafshan S, Sonnenberg JE, Kuczyk MA. Effects of phosphodiesterase inhibitors on the contractile responses of isolated human seminal vesicle tissue to adrenergic stimulation. J Sex Med 2009;6:408-14.
48. Bialy M, Beck J, Abramczyk P, Trzebski A, Przybylski J. Sexual behavior in male rats after nitric oxide synthesis inhibition. Physiol Behav 1996;60:139-43.
49. Aversa A, Francomano D, Bruzziches R, Natali M, Spera G, Lenzi A. Is there a role for phosphodiesterase type-5 inhibitors in the treatment of premature ejaculation? Int J Impot Res 2011;23:17-23.
50. Aversa A, Mazzilli F, Rossi T, Delfino M, Isidori AM, Fabbri A. Effects of sildenafil (Viagra) administration on seminal parameters and post-ejaculatory refractory time in normal males. Hum Reprod 2000;15:131-4.
51. Gokce A, Demirtas A, Halis F, Ekmekcioglu O. In vitro measurement of ejaculation latency time (ELT) and the effects of vardenafil on ELT on lifelong premature ejaculators: Placebo-controlled, double-blind, cross-over laboratory setting. Int Urol Nephrol 2010;42:881-7.
52. Mattos RM, Marmo Lucon A, Srougi M. Tadalafil and fluoxetine in premature ejaculation: Prospective, randomized, double-blind, placebo-controlled study. Urol Int 2008;80:162-5.
53. Jannini EA, Simonelli C, Lenzi A. Sexological approach to ejaculatory dysfunction. Int J Androl 2002;25:317-23.
54. Screponi E, Carosa E, Di Stasi SM, Pepe M, Carruba G, Jannini EA. Prevalence of chronic prostatitis in men with premature ejaculation. Urology 2001;58:198-202.
55. Perelman MA. The sexual tipping point: A mind/body model for sexual medicine. J Sex Med 2009;6:629-32.
56. Jannini EA, McCabe MP, Salonia A, Montorsi F, Sachs BD. Organic vs. psychogenic? The Manichean diagnosis in sexual medicine. J Sex Med 2010;7:1726-33.
57. Althof SE, Rowland DL. Identifying constructs and criteria for the diagnosis of premature ejaculation: Implication for making errors of classification. BJU Int 2008;102:708-12.
58. Development JJPRa. 2010 A prospective randomized, double-blind, placebo-controlled, parallel group, multicenter study of the efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with phosphodiesterase-5 inhibitor. In: Clinicaltrialsgov.